E-ISSN: 2619-9467

Contents    Cover    Publication Date: 06 Jun 2023
Year 2023 - Volume 33 - Issue 2

Open Access

Peer Reviewed

600 Viewed604 Downloaded

Evaluation of the Effect of Delivery Mode on Methylation Changes in the Global DNA and the PTEN Gene

Full Text PDF  
JCOG. 2023;33(2):111-7
DOI: 10.5336/jcog.2022-94979
Article Language: EN
Copyright Ⓒ 2020 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Objective: This study aimed to investigate the association between global DNA and PTEN gene methylation changes and the type of delivery. Material and Methods: The study included a total of 129 pregnant women at the >37th week of pregnancy who had a cesarean (CS) (n=62) or vaginal delivery (VD) (n=67) and their infant's cord blood (n=129). The 5-mC DNA ELISA method performed global DNA methylation analyses, while PTEN gene methylation change analyses were conducted using the methylation-specific polymerase chain reaction method. Results: The global DNA methylation changes in the women in the CS (Group 1) and VD (Group 2) groups and their infants were found to be CS 9.15±4.82, VD 10.6±5.09 (p=0.09); CS 11.3±6.78, and VD 11.7±5.69 (p=0.75), respectively. Based on age, when the global DNA methylation changes were examined in the pregnant women under and over 30, and their infants, the differences in both groups were statistically significant (p=0.05, p=0.015). The PTEN gene methylation rates of the pregnant women in Group 1 (22.5%) were higher than in Group 2 (13.4%). The PTEN gene methylation rates of the infants in Group 1 (17.7%) were higher than those in Group 2 (14.9%). Conclusion: In this study, a significant increase was determined in mothers and infants regarding their global DNA methylation based on age. Our study is also the first study showing gene-specific methylation changes in the PTEN gene. Our findings are believed to pioneer new studies and positively contribute to scientific research.
  1. Declercq E, Menacker F, Macdorman M. Maternal risk profiles and the primary cesarean rate in the United States, 1991-2002. Am J Public Health. 2006;96(5):867-72. [Crossref]  [PubMed]  [PMC] 
  2. Betrán AP, Ye J, Moller AB, Zhang J, Gülmezoglu AM, Torloni MR. The increasing trend in caesarean section rates: global, regional and national estimates: 1990-2014. PLoS One. 2016;11(2):e0148343. [Crossref]  [PubMed]  [PMC] 
  3. T.C. Sağlık Bakanlığı. Sağlık İstatistikleri Yıllığı 2019 Haber Bülteni. [Link] 
  4. Appropriate technology for birth. Lancet. 1985;2(8452):436-7. [Crossref]  [PubMed] 
  5. Cho CE, Norman M. Cesarean section and development of the immune system in the offspring. Am J Obstet Gynecol. 2013;208(4):249-54. [Crossref]  [PubMed] 
  6. Metsälä J, Kilkkinen A, Kaila M, Tapanainen H, Klaukka T, Gissler M, et al. Perinatal factors and the risk of asthma in childhood--a population-based register study in Finland. Am J Epidemiol. 2008;168(2):170-8. [Crossref]  [PubMed]  [PMC] 
  7. Pistiner M, Gold DR, Abdulkerim H, Hoffman E, Celedón JC. Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy. J Allergy Clin Immunol. 2008;122(2):274-9. [Crossref]  [PubMed]  [PMC] 
  8. Kolokotroni O, Middleton N, Gavatha M, Lamnisos D, Priftis KN, Yiallouros PK. Asthma and atopy in children born by caesarean section: effect modification by family history of allergies-a population based cross-sectional study. BMC Pediatr. 2012;12:179. [Crossref]  [PubMed]  [PMC] 
  9. Vehik K, Dabelea D. Why are C-section deliveries linked to childhood type 1 diabetes? Diabetes. 2012;61(1):36-7. [Crossref]  [PubMed]  [PMC] 
  10. Best JD, Carey N. The Epigenetics of Normal Pregnancy. Obstet Med. 2013;6(1):3-7. [Crossref]  [PubMed]  [PMC] 
  11. Fish EW, Shahrokh D, Bagot R, Caldji C, Bredy T, Szyf M, et al. Epigenetic programming of stress responses through variations in maternal care. Ann N Y Acad Sci. 2004;1036:167-80. [Crossref]  [PubMed] 
  12. Ho SM, Johnson A, Tarapore P, Janakiram V, Zhang X, Leung YK. Environmental epigenetics and its implication on disease risk and health outcomes. ILAR J. 2012;53(3-4):289-305. [Crossref]  [PubMed]  [PMC] 
  13. Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet. 2012;13(2):97-109. [Crossref]  [PubMed] 
  14. Dennis C. Epigenetics and disease: altered states. Nature. 2003;421(6924):686-8. [Crossref]  [PubMed] 
  15. Reik W, Dean W. Back to the beginning. Nature. 2002;420(6912):127. [Crossref]  [PubMed] 
  16. Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403(6765):41-5. [Crossref]  [PubMed] 
  17. Drake AJ, Liu L, Kerrigan D, Meehan RR, Seckl JR. Multigenerational programming in the glucocorticoid programmed rat is associated with generation-specific and parent of origin effects. Epigenetics. 2011;6(11):1334-43. [Crossref]  [PubMed] 
  18. Schlinzig T, Johansson S, Gunnar A, Ekström TJ, Norman M. Epigenetic modulation at birth - altered DNA-methylation in white blood cells after Caesarean section. Acta Paediatr. 2009;98(7):1096-9. [Crossref]  [PubMed] 
  19. Virani S, Dolinoy DC, Halubai S, Jones TR, Domino SE, Rozek LS, et al. Delivery type not associated with global methylation at birth. Clin Epigenetics. 2012;4(1):8. [Crossref]  [PubMed]  [PMC] 
  20. Park JH, Stoffers DA, Nicholls RD, Simmons RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest. 2008;118(6):2316-24. [Crossref]  [PubMed]  [PMC] 
  21. Radford EJ, Isganaitis E, Jimenez-Chillaron J, Schroeder J, Molla M, Andrews S, et al. An unbiased assessment of the role of imprinted genes in an intergenerational model of developmental programming. PLoS Genet. 2012;8(4):e1002605. [Crossref]  [PubMed]  [PMC] 
  22. Li Y, Wang XY, Wu T, Chuai M, Lee KK, Wang LJ, et al. PTEN is involved in modulation of vasculogenesis in early chick embryos. Biol Open. 2013;2(6):587-95. [Crossref]  [PubMed]  [PMC] 
  23. Gupta A, Anjomani-Virmouni S, Koundouros N, Dimitriadi M, Choo-Wing R, Valle A, et al. PARK2 depletion connects energy and oxidative stress to PI3K/Akt activation via PTEN S-nitrosylation. Mol Cell. 2017;65(6):999-1013.e7. [Crossref]  [PubMed]  [PMC] 
  24. McBride KL, Varga EA, Pastore MT, Prior TW, Manickam K, Atkin JF, et al. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res. 2010;3(3):137-41. [Crossref]  [PubMed] 
  25. Li J, Gong P, Lyu X, Yao K, Li X, Peng H. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker. Oncol Rep. 2014;31(5):2206-12. [Crossref]  [PubMed] 
  26. Liu L, Li Y, Tollefsbol TO. Gene-environment interactions and epigenetic basis of human diseases. Curr Issues Mol Biol. 2008;10(1-2):25-36. [PubMed]  [PMC] 
  27. Yektaei-Karin E, Moshfegh A, Lundahl J, Berggren V, Hansson LO, Marchini G. The stress of birth enhances in vitro spontaneous and IL-8-induced neutrophil chemotaxis in the human newborn. Pediatr Allergy Immunol. 2007;18(8):643-51. [Crossref]  [PubMed] 
  28. Knafo S, Esteban JA. PTEN: Local and Global Modulation of Neuronal Function in Health and Disease. Trends Neurosci. 2017;40(2):83-91. [Crossref]  [PubMed] 
  29. Virani S, Dolinoy DC, Halubai S, Jones TR, Domino SE, Rozek LS, et al. Delivery type not associated with global methylation at birth. Clin Epigenetics. 2012;4(1):8. [Crossref]  [PubMed]  [PMC] 
  30. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-217. [Crossref]  [PubMed]  [PMC] 
  31. Field AE, Robertson NA, Wang T, Havas A, Ideker T, Adams PD. DNA methylation clocks in aging: categories, causes, and consequences. Mol Cell. 2018;71(6):882-95. [Crossref]  [PubMed]  [PMC] 
  32. Johnson AA, Akman K, Calimport SR, Wuttke D, Stolzing A, de Magalhães JP. The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuvenation Res. 2012;15(5):483-94. [Crossref]  [PubMed]  [PMC] 
  33. Piras G, Monne M, Palmas AD, Calvisi A, Asproni R, Vacca F, et al. Methylation analysis of the phosphates and tensin homologue on chromosome 10 gene (PTEN) in multiple myeloma. Clin Epigenetics. 2014;6(1):16. [Crossref]  [PubMed]  [PMC] 
  34. Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamgüney T, et al. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol. 2007;9(3):271-9. [Crossref]  [PubMed]  [PMC] 
  35. Phuong NT, Kim SK, Lim SC, Kim HS, Kim TH, Lee KY, et al. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells. Breast Cancer Res Treat. 2011;130(1):73-83. [Crossref]  [PubMed]